Use of Total Lymphocyte Count for Monitoring Response to Antiretroviral Therapy
Open Access
- 15 January 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (2) , 257-262
- https://doi.org/10.1086/380792
Abstract
The CD4 cell count has become a key laboratory measurement in the management of human immunodeficiency virus (HIV) disease. In ideal situations, HIV-infected persons are followed up longitudinally with serial CD4 cell counts to determine disease progression, risk for opportunistic infection, and the need for prophylactic or therapeutic intervention. However, the use of the CD4 cell count in resource-limited settings is often not possible because of lack of availability and high cost. Thus, other laboratory markers have been proposed as substitutes for the CD4 cell count. The data regarding the clinical utility of the total lymphocyte count (TLC) as a potential surrogate marker of immune function in patients with HIV disease are examined. The role of the TLC in the initiation of antiretroviral therapy and opportunistic infection prophylaxis, as well as the role of the TLC in monitoring the response to antiretroviral therapy, are also addressed.Keywords
This publication has 15 references indexed in Scilit:
- Human Immunodeficiency Virus–1 RNA Levels and CD4 Lymphocyte Counts, during Treatment for Active Tuberculosis, in South African PatientsThe Journal of Infectious Diseases, 2003
- Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settingsAIDS, 2003
- Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settingsAIDS, 2003
- Rapid declines in total lymphocyte count and hemoglobin in HIV infection begin at CD4 lymphocyte counts that justify antiretroviral therapyAIDS, 2003
- Total Lymphocyte Count (TLC) Is a Useful Tool for the Timing of Opportunistic Infection Prophylaxis in India and Other Resource-Constrained CountriesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Challenges in delivering antiretroviral treatment in resource poor countriesAIDS, 2002
- Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markersAIDS, 1999
- Correlation Among Total Lymphocyte Count, Absolute CD4+ Count, and CD4+ Percentage in a Group of HIV-1-Infected South African PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- CD4 and total lymphocyte counts as predictors of HIV disease progressionQJM: An International Journal of Medicine, 1996
- Total lymphocyte count as a predictor of absolute CD4+ count and CD4+ percentage in HIV-infected personsPublished by American Medical Association (AMA) ,1993